Follow-up interval | Favorable | Rejection | P | ||||
---|---|---|---|---|---|---|---|
n | Mean (%) | SD (%) | n | Mean (%) | SD (%) | ||
Baseline | |||||||
RP | 10 | 43.6 | 8.7 | 6 | 38.8 | 12.2 | 0.376 |
FEV1 | 10 | 22.4 | 7.0 | 6 | 24.0 | 6.4 | 0.656 |
Early (1–3 mo) | |||||||
Minimal RP | 8 | 67.1 | 12.2 | 6 | 50.8 | 9.6 | 0.020 |
Minimal FEV1 | 10 | 55.1 | 16.9 | 6 | 45.8 | 15.9 | 0.298 |
Maximal RP | 8 | 70.6 | 11.2 | 6 | 58.2 | 13.1 | 0.079 |
Maximal FEV1 | 10 | 59.1 | 16.9 | 6 | 57.0 | 10.1 | 0.871 |
Late (1–3 y) | |||||||
Minimal RP | 10 | 72.3 | 10.0 | 7 | 61.9 | 17.2 | 0.134 |
Minimal FEV1 | 10 | 56.9 | 13.6 | 7 | 35.6 | 7.9 | 0.002 |
Maximal RP | 10 | 76.5 | 8.9 | 7 | 64.3 | 15.0 | 0.051 |
Maximal FEV1 | 10 | 63.5 | 14.1 | 7 | 46.1 | 11.0 | 0.016 |
n = number of patients for whom test values were available; RP = relative perfusion.